Swiss Soliris® aHUS Reimbursement Registry SSaRR: Observational registry of patients suffering from atypical Hemolytic Uremic Syndrome (aHUS) who are treated with Soliris® (Eculizumab) First published 22/09/2020 Last updated 23/04/2024 EU PAS number:EUPAS37301 Study Ongoing